If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
GASTROENTEROLOGY
EMJ Gastroenterol. 2018 Suppl 1 • europeanmedical-journal.com
INSIDE
Keep CALM and Use Biomarkers
in Inflammatory Bowel Disease
Keep CALM and Use Biomarkers
in Inflammatory Bowel Disease
This symposium took place on 15th February 2018, as part of the
13th Congress of the European Crohn’s and Colitis Organisation
(ECCO) in Vienna, Austria
Chairperson: Remo Panaccione1
Speakers: Remo Panaccione,1 Jonas Halfvarson,2 Peter Bossuyt3
1. University of Calgary, Calgary, Canada
2. Department of Gastroenterology, Faculty of Medicine and Health,
Örebro University, Örebro, Sweden
3. Imelda GI Clinical Research Centre, IBD Clinic Imelda General Hospital,
Bonheiden, Belgium
Disclosure: Prof Panaccione has acted as a consultant and/or advisory board member for
GASTROENTEROLOGY EMJ Gastroenterol. 2018 Suppl 1
Keep CALM and Use Biomarkers in Inflammatory Bowe
treatment.2 Dr Halfvarson discussed the current u
were available, biomarkers were not regarded as
Can We Trust Biomarkers in Inflammatory Bowel
100 80 60 Patients (%) 40 20 0 Clinic
In summary, biomarkers are reliable tools i
p=0.021 30 20 Events/100 PY 10 0 28.0 29
References 1. M’Koma AE. Inflammatory bowel
illness review. Can J Gastroenterol.